Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 276

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 276
---
, twelve months after the date of closing; and for one-third of the shares, twenty-four months after the date of closing; (b) the date on which the closing price of the ParentCo Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and similar transactions) for any 20 trading days within any 30-trading day period or (c) the date on which ParentCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of ParentCo’s stockholders having the right to exchange their shares of ParentCo common stock for cash, securities or other property.

For more information about the Amended and Restated Registration Rights Agreement, see the section entitled “ Proposal 1 — The Business Combination Proposal — Additional Agreements Executed at the Signing of the Business Combination Agreement — Lock-Up Agreement .”

#### Rule 144
Pursuant to Rule 144 under the Securities Act, a person who has beneficially owned restricted ParentCo Common Stock or ParentCo Warrants for at least six months would be entitled to sell their securities provided that (i) such person is not deemed to have been one of ParentCo’s affiliates at the time of, or at any time during the three months preceding, a sale and (ii) ParentCo is subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section 13

<div align='center'>137</div>

TABLE OF CONTENTS

or 15(d) of the Exchange Act during the 12 months (or such shorter period as ParentCo was were required to file reports) preceding the sale.

Persons who have beneficially owned restricted ParentCo Common Stock or ParentCo Warrants for at least six months but who are affiliates of ParentCo at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following:

•

1% of the total number of shares of ParentCo Common Stock or warrants then outstanding, as applicable; or

•

the average weekly reported trading volume of ParentCo Common Stock or ParentCo Warrants, as applicable, during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

Sales by affiliates of ParentCo under Rule 144